Comment on: Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis

被引：0
|
作者：
Misra, Durga Prasanna [1 ,2 ]
机构：
[1] Sanjay Gandhi Postgrad Inst Med Sci SGPGIMS, Dept Clin Immunol & Rheumatol, Lucknow, India
[2] Sanjay Gandhi Postgrad Inst Med Sci SGPGIMS, Dept Clin Immunol & Rheumatol, Rae Bareli Rd, Lucknow 226014, India
来源：
RHEUMATOLOGY | 2024年 / 63卷 / 05期
关键词：
D O I：
10.1093/rheumatology/keae013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e156 / e157
页数：2
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF TOCILIZUMAB MONOTHERAPY VERSUS ADALIMUMAB MONOTHERAPY IN THE TREATMENT OF SEVERE ACTIVE RA
    Carlson, J. J.
    Ogale, S.
    Dejonckheere, F.
    Sullivan, S. D.
    VALUE IN HEALTH, 2012, 15 (07) : A447 - A447
  • [32] Successful Tocilizumab Treatment in a Child With Refractory Takayasu Arteritis
    Bravo Mancheno, Beatriz
    Perin, Francesca
    Rodriguez Vazquez del Rey, Maria del Mar
    Garcia Sanchez, Antonio
    Alcazar Romero, Pedro Pablo
    PEDIATRICS, 2012, 130 (06) : E1720 - E1724
  • [33] LONG-TERM EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH REFRACTORY TAKAYASU ARTERITIS: FINAL RESULTS FROM THE TAKT STUDY
    Nakaoka, Yoshikazu
    Yamashita, Katsuhisa
    Okada, Norihiro
    Yamakido, Shinji
    RHEUMATOLOGY, 2019, 58
  • [34] Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis
    Lili Pan
    Juan Du
    Jiayi Liu
    Hua Liao
    Xiaoli Liu
    Xi Guo
    Jing Liang
    Hongya Han
    Lixia Yang
    Yujie Zhou
    Clinical Rheumatology, 2020, 39 : 2369 - 2378
  • [35] EFFICACY AND SAFETY OF TNF-A ANTAGONISTS AND TOCILIZUMAB IN TAKAYASU ARTERITIS: MULTICENTER EUROPEAN RETROSPECTIVE STUDY OF 203 PATIENTS.
    Mekinian, A.
    Vautier, M.
    Resche-Rigon, M.
    Dagna, L.
    Sciascia, S.
    Cacoub, P.
    Fain, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1548 - 1548
  • [36] Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis
    Pan, Lili
    Du, Juan
    Liu, Jiayi
    Liao, Hua
    Liu, Xiaoli
    Guo, Xi
    Liang, Jing
    Han, Hongya
    Yang, Lixia
    Zhou, Yujie
    CLINICAL RHEUMATOLOGY, 2020, 39 (08) : 2369 - 2378
  • [37] Effectiveness and safety of adalimumab compared with leflunomide in patients with Takayasu arteritis: a retrospective cohort study
    Peron Filho, Faustino
    Moreira, Andressa de Souza
    Janes, Anna Larissa Faria
    de Souza, Alexandre W. S.
    RMD OPEN, 2024, 10 (01):
  • [38] EFFICACY AND SAFETY OF TOCILIZUMAB IN THE TREATMENT OF SEVERE JUVENILE DERMATOMYOSITIS
    Chi, Ying
    Li, Jian-Guo
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 573 - 573
  • [39] Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review
    Haiyan Li
    Zongwen Shuai
    Heart and Vessels, 2022, 37 : 884 - 894
  • [40] Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review
    Li, Haiyan
    Shuai, Zongwen
    HEART AND VESSELS, 2022, 37 (05) : 884 - 894
12345